title: Is it not timely to consider how to balance cardiorenometabolic benefits and risks of statins?
authors.forename: Kwang Kon
authors.initials: KK
authors.lastname: Koh
mesh_terms: D001013:Aorta, Thoracic / Q000000981:diagnostic imaging*; D050197:Atherosclerosis / Q000188:drug therapy*; D002339:Carotid Arteries / Q000000981:diagnostic imaging*; D005260:Female; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007249:Inflammation / Q000188:drug therapy*; D008297:Male; D058226:Plaque, Atherosclerotic / Q000188:drug therapy*; D011758:Pyrroles / Q000627:therapeutic use*; D011877:Radionuclide Imaging
chemical_list: D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles